Literature DB >> 4064018

Classification and management of the slit ventricle syndrome.

W Serlo, E Heikkinen, A L Saukkonen, L von Wendt.   

Abstract

A total of 32 patients with overdrainage of CSF, fulfilling the radiological and clinical criteria for collapsed ventricles ("slit ventricles"), were classified into acute, subacute and chronic forms. The basis of classification into these categories was neurologic symptomatology. The majority (29 patients) originally had a ventriculoatrial shunt and 3 had ventriculoperitoneal shunts. Operative correction was performed in 23 patients (insertion of a high pressure valve in 18 and an antisiphon device in 5). Of these, 5 had acute, 10 subacute, and 6 chronic symptoms. Two patients without symptoms were operated on also. During the follow-up period, which varied from 2 to 11 months, no patient has shown recurrence of the original symptoms of the slit ventricle syndrome; two patients developed subacute signs and an antisiphon device was inserted in addition to the high-resistance valve. On the basis of this series, it is concluded that the slit ventricle syndrome can also develop in patients with an atrioventricular shunt and can be treated by preventing further overdrainage of CSF. Though the results are acceptable by present methods, the need for a servo-regulated shunt persists. The surgical correction should preferably be performed before the acute phase. A flowchart is presented for management of a child with suspected slit ventricles.

Entities:  

Mesh:

Year:  1985        PMID: 4064018     DOI: 10.1007/BF00270761

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  16 in total

1.  Experimental negative intraventricular pressures.

Authors:  W A Shucart; R Connolly
Journal:  J Surg Res       Date:  1975-07       Impact factor: 2.192

2.  Treatment of hydrocephalus by direct shunt from ventricle to jugular vain.

Authors:  F E NULSEN; E B SPITZ
Journal:  Surg Forum       Date:  1951

3.  Anti-siphon and reversible occlusion valves for shunting in hydrocephalus and preventing post-shunt subdural hematomas.

Authors:  H D Portnoy; R R Schulte; J L Fox; P D Croissant; L Tripp
Journal:  J Neurosurg       Date:  1973-06       Impact factor: 5.115

4.  The collapsed ventricle: management and prevention.

Authors:  J H Salmon
Journal:  Surg Neurol       Date:  1978-06

5.  Effect of respiratory movement on cerebrospinal fluid dynamics in hydrocephalic infants with shunts.

Authors:  H Yamada; M Tajima; M Nagaya
Journal:  J Neurosurg       Date:  1975-02       Impact factor: 5.115

6.  Overdrainage phenomena in shunt treated hydrocephalus.

Authors:  K Faulhauer; P Schmitz
Journal:  Acta Neurochir (Wien)       Date:  1978       Impact factor: 2.216

7.  Should "normalisation" of the ventricles be the goal of hydrocephalus therapy.

Authors:  R Gruber
Journal:  Z Kinderchir       Date:  1983-12

8.  Cerebrospinal fluid pressure.

Authors:  K C Bradley
Journal:  J Neurol Neurosurg Psychiatry       Date:  1970-06       Impact factor: 10.154

9.  Subtemporal decompression for the slit-ventricle syndrome after shunting in hydrocephalic children.

Authors:  R O Holness; H J Hoffman; E B Hendrick
Journal:  Childs Brain       Date:  1979

10.  Effect of cerebrospinal fluid shunts on intracranial pressure and on cerebrospinal fluid dynamics. 2. A new technique of pressure measurements: results and concepts. 3. A concept of hydrocephalus.

Authors:  J L Fox; D C McCullough; R C Green
Journal:  J Neurol Neurosurg Psychiatry       Date:  1973-04       Impact factor: 10.154

View more
  17 in total

1.  Evaluation of cerebrospinal fluid shunt function in hydrocephalic children using 99mTc-DTPA.

Authors:  P Uvebrant; R Sixt; J Bjure; A Roos
Journal:  Childs Nerv Syst       Date:  1992-03       Impact factor: 1.475

Review 2.  Craniocerebral disproportion: a topical review and proposal toward a new definition, diagnosis, and treatment protocol.

Authors:  Adam L Sandler; James T Goodrich; Lawrence B Daniels; Arundhati Biswas; Rick Abbott
Journal:  Childs Nerv Syst       Date:  2013-08-24       Impact factor: 1.475

3.  Slit ventricle syndrome after cyst-peritoneal shunting for the treatment of intracranial arachnoid cyst.

Authors:  N Aoki; T Sakai; Y Umezawa
Journal:  Childs Nerv Syst       Date:  1990-01       Impact factor: 1.475

Review 4.  The truth and coherence behind the concept of overdrainage of cerebrospinal fluid in hydrocephalic patients.

Authors:  Stephanie Cheok; Jason Chen; Jorge Lazareff
Journal:  Childs Nerv Syst       Date:  2014-01-15       Impact factor: 1.475

Review 5.  Shunts vs endoscopic third ventriculostomy in infants: are there different types and/or rates of complications? A review.

Authors:  C Di Rocco; L Massimi; G Tamburrini
Journal:  Childs Nerv Syst       Date:  2006-10-20       Impact factor: 1.475

6.  Upward ballooning of the third ventricle floor in a patient with slit ventricle syndrome: A unique magnetic resonance imaging finding.

Authors:  Junya Yamaguchi; Tadashi Watanabe; Yuichi Nagata; Tetuya Nagatani; Yukio Seki
Journal:  Neuroradiol J       Date:  2016-11-25

7.  Reexpandability of the ventricular system of hydrocephalic children in the event of shunt occlusion.

Authors:  Hiroaki Sakamoto; Shouhei Kitano
Journal:  Childs Nerv Syst       Date:  2006-02-24       Impact factor: 1.475

Review 8.  Is the slit ventricle syndrome always a slit ventricle syndrome?

Authors:  C Di Rocco
Journal:  Childs Nerv Syst       Date:  1994-01       Impact factor: 1.475

9.  Intracranial pressure monitoring using a programmable pressure valve and a telemetric intracranial pressure sensor in a case of slit ventricle syndrome after multiple shunt revisions.

Authors:  T Kamiryo; Y Fujii; M Kusaka; S Kashiwagi; H Ito
Journal:  Childs Nerv Syst       Date:  1991-08       Impact factor: 1.475

10.  The "steppingstone" phenomenon: a new endoscopic finding in slit-ventricle syndrome.

Authors:  Yuichi Nagata; Kazuhito Takeuchi; Mihoko Kato; Hirokatsu Osawa; Tadashi Watanabe; Toshihiko Wakabayashi
Journal:  Childs Nerv Syst       Date:  2016-05-21       Impact factor: 1.475

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.